Cargando…
SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer
The suppressor of cytokine signaling (SOCS) family contains eight members, including SOCS1–7 and CIS, and SOCS3 has been shown to inhibit cytokine signal transduction in various signaling pathways. Although several studies have currently shown the correlations between SOCS3 and several types of canc...
Autores principales: | Dai, Lirui, Tao, Yiran, Shi, Zimin, Liang, Wulong, Hu, Weihua, Xing, Zhe, Zhou, Shaolong, Guo, Xuyang, Fu, Xudong, Wang, Xinjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122507/ https://www.ncbi.nlm.nih.gov/pubmed/35600392 http://dx.doi.org/10.3389/fonc.2022.881801 |
Ejemplares similares
-
SOCS proteins and their roles in the development of glioblastoma
por: Dai, Lirui, et al.
Publicado: (2022) -
Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types
por: Dai, Lirui, et al.
Publicado: (2023) -
Identification and validation of SOCS1/2/3/4 as potential prognostic biomarkers and correlate with immune infiltration in glioblastoma
por: Dai, Lirui, et al.
Publicado: (2023) -
Systematic characterization and biological functions of non‐coding RNAs in glioblastoma
por: Dai, Lirui, et al.
Publicado: (2022) -
Cholesterol metabolism and its implication in glioblastoma therapy
por: Guo, Xuyang, et al.
Publicado: (2022)